Annual EBIT
-$212.69 M
-$124.15 M-140.22%
December 31, 2023
Summary
- As of February 7, 2025, TNDM annual earnings before interest & taxes is -$212.69 million, with the most recent change of -$124.15 million (-140.22%) on December 31, 2023.
- During the last 3 years, TNDM annual EBIT has fallen by -$188.56 million (-781.47%).
- TNDM annual EBIT is now -1152.19% below its all-time high of $20.21 million, reached on December 31, 2021.
Performance
TNDM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$20.75 M
+$7.20 M+25.76%
September 30, 2024
Summary
- As of February 7, 2025, TNDM quarterly earnings before interest & taxes is -$20.75 million, with the most recent change of +$7.20 million (+25.76%) on September 30, 2024.
- Over the past year, TNDM quarterly EBIT has increased by +$9.36 million (+31.10%).
- TNDM quarterly EBIT is now -196.22% below its all-time high of $21.56 million, reached on December 31, 2020.
Performance
TNDM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$117.20 M
+$5.84 M+4.75%
September 30, 2024
Summary
- As of February 7, 2025, TNDM TTM earnings before interest & taxes is -$117.20 million, with the most recent change of +$5.84 million (+4.75%) on September 30, 2024.
- Over the past year, TNDM TTM EBIT has increased by +$95.04 million (+44.78%).
- TNDM TTM EBIT is now -496.55% below its all-time high of $29.55 million, reached on September 30, 2021.
Performance
TNDM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TNDM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -140.2% | +31.1% | +44.8% |
| 3 y3 years | -781.5% | +37.2% | +46.0% |
| 5 y5 years | -85.0% | +37.2% | +46.0% |
TNDM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1152.2% | at low | -269.7% | +83.1% | -679.8% | +46.0% |
| 5 y | 5-year | -1152.2% | at low | -196.2% | +83.1% | -496.6% | +46.0% |
| alltime | all time | -1152.2% | at low | -196.2% | +83.1% | -496.6% | +46.0% |
Tandem Diabetes Care EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.75 M(-25.8%) | -$117.20 M(-4.7%) |
| Jun 2024 | - | -$27.95 M(-27.2%) | -$123.04 M(-4.0%) |
| Mar 2024 | - | -$38.38 M(+27.5%) | -$128.11 M(-39.6%) |
| Dec 2023 | -$212.69 M(+140.2%) | -$30.11 M(+13.2%) | -$212.24 M(+7.6%) |
| Sep 2023 | - | -$26.59 M(-19.5%) | -$197.16 M(-9.1%) |
| Jun 2023 | - | -$33.02 M(-73.0%) | -$216.84 M(+10.8%) |
| Mar 2023 | - | -$122.51 M(+714.8%) | -$195.69 M(+121.0%) |
| Dec 2022 | -$88.54 M(-538.0%) | -$15.04 M(-67.5%) | -$88.54 M(+44.5%) |
| Sep 2022 | - | -$46.27 M(+289.7%) | -$61.28 M(+658.1%) |
| Jun 2022 | - | -$11.87 M(-22.7%) | -$8.08 M(-190.5%) |
| Mar 2022 | - | -$15.36 M(-225.7%) | $8.94 M(-55.8%) |
| Dec 2021 | $20.21 M(-183.8%) | $12.22 M(+76.5%) | $20.21 M(-31.6%) |
| Sep 2021 | - | $6.93 M(+34.6%) | $29.55 M(+65.4%) |
| Jun 2021 | - | $5.15 M(-226.1%) | $17.87 M(-232.9%) |
| Mar 2021 | - | -$4.08 M(-118.9%) | -$13.44 M(-44.3%) |
| Dec 2020 | -$24.13 M(-1.9%) | $21.56 M(-553.2%) | -$24.13 M(-43.8%) |
| Sep 2020 | - | -$4.76 M(-81.8%) | -$42.96 M(+4.7%) |
| Jun 2020 | - | -$26.16 M(+77.2%) | -$41.03 M(+150.6%) |
| Mar 2020 | - | -$14.77 M(-641.2%) | -$16.37 M(-33.4%) |
| Dec 2019 | -$24.60 M(-78.6%) | $2.73 M(-196.5%) | -$24.59 M(+4.2%) |
| Sep 2019 | - | -$2.83 M(+88.2%) | -$23.60 M(-56.0%) |
| Jun 2019 | - | -$1.50 M(-93.5%) | -$53.62 M(-50.5%) |
| Mar 2019 | - | -$22.99 M(-718.7%) | -$108.36 M(-5.8%) |
| Dec 2018 | -$115.00 M | $3.71 M(-111.3%) | -$115.00 M(-9.6%) |
| Sep 2018 | - | -$32.84 M(-41.6%) | -$127.22 M(+18.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$56.25 M(+89.9%) | -$107.48 M(+53.2%) |
| Mar 2018 | - | -$29.62 M(+248.4%) | -$70.14 M(+13.7%) |
| Dec 2017 | -$61.68 M(-20.7%) | -$8.50 M(-35.1%) | -$61.68 M(-7.2%) |
| Sep 2017 | - | -$13.11 M(-30.7%) | -$66.49 M(-18.7%) |
| Jun 2017 | - | -$18.91 M(-10.7%) | -$81.76 M(+2.5%) |
| Mar 2017 | - | -$21.17 M(+59.1%) | -$79.80 M(+2.6%) |
| Dec 2016 | -$77.75 M(+13.2%) | -$13.31 M(-53.1%) | -$77.75 M(+2.9%) |
| Sep 2016 | - | -$28.38 M(+67.5%) | -$75.58 M(+14.8%) |
| Jun 2016 | - | -$16.95 M(-11.4%) | -$65.81 M(-2.5%) |
| Mar 2016 | - | -$19.12 M(+71.8%) | -$67.48 M(-1.7%) |
| Dec 2015 | -$68.67 M(-9.1%) | -$11.13 M(-40.2%) | -$68.67 M(-8.5%) |
| Sep 2015 | - | -$18.62 M(+0.0%) | -$75.01 M(-0.5%) |
| Jun 2015 | - | -$18.61 M(-8.4%) | -$75.37 M(+0.4%) |
| Mar 2015 | - | -$20.31 M(+16.3%) | -$75.04 M(-0.7%) |
| Dec 2014 | -$75.55 M(+29.3%) | -$17.47 M(-7.9%) | -$75.55 M(-6.2%) |
| Sep 2014 | - | -$18.98 M(+3.8%) | -$80.53 M(+9.7%) |
| Jun 2014 | - | -$18.29 M(-12.2%) | -$73.41 M(+6.0%) |
| Mar 2014 | - | -$20.82 M(-7.2%) | -$69.25 M(+18.5%) |
| Dec 2013 | -$58.43 M(+91.6%) | -$22.45 M(+89.3%) | -$58.43 M(+31.5%) |
| Sep 2013 | - | -$11.86 M(-16.1%) | -$44.43 M(+13.8%) |
| Jun 2013 | - | -$14.13 M(+41.4%) | -$39.04 M(+56.7%) |
| Mar 2013 | - | -$10.00 M(+18.3%) | -$24.91 M(+67.0%) |
| Dec 2012 | -$30.49 M(+22.1%) | -$8.45 M(+30.7%) | -$14.91 M(+130.7%) |
| Sep 2012 | - | -$6.47 M | -$6.47 M |
| Dec 2011 | -$24.97 M | - | - |
FAQ
- What is Tandem Diabetes Care annual earnings before interest & taxes?
- What is the all time high annual EBIT for Tandem Diabetes Care?
- What is Tandem Diabetes Care annual EBIT year-on-year change?
- What is Tandem Diabetes Care quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Tandem Diabetes Care?
- What is Tandem Diabetes Care quarterly EBIT year-on-year change?
- What is Tandem Diabetes Care TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Tandem Diabetes Care?
- What is Tandem Diabetes Care TTM EBIT year-on-year change?
What is Tandem Diabetes Care annual earnings before interest & taxes?
The current annual EBIT of TNDM is -$212.69 M
What is the all time high annual EBIT for Tandem Diabetes Care?
Tandem Diabetes Care all-time high annual earnings before interest & taxes is $20.21 M
What is Tandem Diabetes Care annual EBIT year-on-year change?
Over the past year, TNDM annual earnings before interest & taxes has changed by -$124.15 M (-140.22%)
What is Tandem Diabetes Care quarterly earnings before interest & taxes?
The current quarterly EBIT of TNDM is -$20.75 M
What is the all time high quarterly EBIT for Tandem Diabetes Care?
Tandem Diabetes Care all-time high quarterly earnings before interest & taxes is $21.56 M
What is Tandem Diabetes Care quarterly EBIT year-on-year change?
Over the past year, TNDM quarterly earnings before interest & taxes has changed by +$9.36 M (+31.10%)
What is Tandem Diabetes Care TTM earnings before interest & taxes?
The current TTM EBIT of TNDM is -$117.20 M
What is the all time high TTM EBIT for Tandem Diabetes Care?
Tandem Diabetes Care all-time high TTM earnings before interest & taxes is $29.55 M
What is Tandem Diabetes Care TTM EBIT year-on-year change?
Over the past year, TNDM TTM earnings before interest & taxes has changed by +$95.04 M (+44.78%)